Clinical Trial

Tech-based Respite Care for Caregivers and Homebound Older Adults

Study acronym: TechRespiteRCT
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to examine the effectiveness of VR-based respite in improving cognitive function, mental health, and quality of life in caregivers and homebound older adults compared to a control group using videos and a usual care group. Participants are randomly assigned to one of three groups: VR intervention, video control, or usual care. The VR group receives immersive VR sessions using the SilVR Adventures platform. The video group receives non-immersive video sessions with similar content. The usual care group receives no additional intervention. Assessments are conducted at baseline, immediate post-intervention, and 3 months post-intervention to measure changes in depression, anxiety, loneliness, quality of life, and other outcomes. The intervention dosage will be 4 weeks (1 sessions/week; 30 min/session). Secondarily, the study explores differences in effectiveness between caregivers and homebound older adults, and potential moderators or mediators such as baseline health status, technological literacy, and social support.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-29; most recent amendment 2026-07-20.
Status change: Not Yet Recruiting → Recruiting 2026-07-20
Trial Details
NCT Number NCT07160673
Lead Sponsor Hong Kong University
Conditions Caregiver Stress, Social Isolation in Older Adults, Cognitive Decline in Older Adults, Depression in Older Adults, Anxiety in Older Adults
Enrollment 180 participants
Start Date 2025-09-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-08-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-22